124 related articles for article (PubMed ID: 34818230)
1. Camptothecin-Induced Replication Stress Affects DNA Replication Profiling by E/L Repli-Seq.
Hayakawa T; Suzuki R; Kagotani K; Okumura K; Takebayashi SI
Cytogenet Genome Res; 2021; 161(8-9):437-444. PubMed ID: 34818230
[TBL] [Abstract][Full Text] [Related]
2. Mapping Replication Timing in Single Mammalian Cells.
Bartlett DA; Dileep V; Baslan T; Gilbert DM
Curr Protoc; 2022 Jan; 2(1):e334. PubMed ID: 34986273
[TBL] [Abstract][Full Text] [Related]
3. Camptothecin, a specific inhibitor of type I DNA topoisomerase, induces DNA breakage at replication forks.
Avemann K; Knippers R; Koller T; Sogo JM
Mol Cell Biol; 1988 Aug; 8(8):3026-34. PubMed ID: 2850477
[TBL] [Abstract][Full Text] [Related]
4. Repli-seq Sample Preparation using Cell Sorting with Cell-Permeant Dyes.
Meyer-Nava S; Shetty AV; Rivera-Mulia JC
Curr Protoc; 2023 Nov; 3(11):e945. PubMed ID: 38009262
[TBL] [Abstract][Full Text] [Related]
5. Tipin functions in the protection against topoisomerase I inhibitor.
Hosono Y; Abe T; Higuchi M; Kajii K; Sakuraba S; Tada S; Enomoto T; Seki M
J Biol Chem; 2014 Apr; 289(16):11374-11384. PubMed ID: 24573676
[TBL] [Abstract][Full Text] [Related]
6. Genome-wide analysis of replication timing by next-generation sequencing with E/L Repli-seq.
Marchal C; Sasaki T; Vera D; Wilson K; Sima J; Rivera-Mulia JC; Trevilla-García C; Nogues C; Nafie E; Gilbert DM
Nat Protoc; 2018 May; 13(5):819-839. PubMed ID: 29599440
[TBL] [Abstract][Full Text] [Related]
7. Topoisomerase I poisoning results in PARP-mediated replication fork reversal.
Ray Chaudhuri A; Hashimoto Y; Herrador R; Neelsen KJ; Fachinetti D; Bermejo R; Cocito A; Costanzo V; Lopes M
Nat Struct Mol Biol; 2012 Mar; 19(4):417-23. PubMed ID: 22388737
[TBL] [Abstract][Full Text] [Related]
8. Nascent DNA Proteomics Reveals a Chromatin Remodeler Required for Topoisomerase I Loading at Replication Forks.
Ribeyre C; Zellweger R; Chauvin M; Bec N; Larroque C; Lopes M; Constantinou A
Cell Rep; 2016 Apr; 15(2):300-9. PubMed ID: 27050524
[TBL] [Abstract][Full Text] [Related]
9. Involvement of topoisomerases in replication, transcription, and packaging of the linear adenovirus genome.
Wong ML; Hsu MT
J Virol; 1990 Feb; 64(2):691-9. PubMed ID: 2153235
[TBL] [Abstract][Full Text] [Related]
10. High-resolution Repli-Seq defines the temporal choreography of initiation, elongation and termination of replication in mammalian cells.
Zhao PA; Sasaki T; Gilbert DM
Genome Biol; 2020 Mar; 21(1):76. PubMed ID: 32209126
[TBL] [Abstract][Full Text] [Related]
11. Characterization of a camptothecin-resistant human DNA topoisomerase I in an in vitro system for Simian virus 40 DNA replication.
Ishimi Y; Nishizawa M; Andoh T
Eur J Biochem; 1991 Dec; 202(3):835-9. PubMed ID: 1662615
[TBL] [Abstract][Full Text] [Related]
12. Comparison of effects of fostriecin, novobiocin, and camptothecin, inhibitors of DNA topoisomerases, on DNA replication and repair in human cells.
Gedik CM; Collins AR
Nucleic Acids Res; 1990 Feb; 18(4):1007-13. PubMed ID: 2156221
[TBL] [Abstract][Full Text] [Related]
13. Inhibitors of topoisomerases I and II arrest DNA replication, but do not prevent nucleosome assembly in vivo.
Annunziato AT
J Cell Sci; 1989 Aug; 93 ( Pt 4)():593-603. PubMed ID: 2558122
[TBL] [Abstract][Full Text] [Related]
14. The human cell multiprotein DNA replication complex (MRC): the effect of camptothecin on its ability to support in vitro DNA synthesis.
Coll JM; Hickey RJ; Wei Y; Malkas LH
Cancer Chemother Pharmacol; 1996; 39(1-2):97-102. PubMed ID: 8995505
[TBL] [Abstract][Full Text] [Related]
15. Differences in induction of p53, p21WAF1 and apoptosis in relation to cell cycle phase of MCF-7 cells treated with camptothecin.
Deptala A; Li X; Bedner E; Cheng W; Traganos F; Darzynkiewicz Z
Int J Oncol; 1999 Nov; 15(5):861-71. PubMed ID: 10536167
[TBL] [Abstract][Full Text] [Related]
16. Inhibition of replicon initiation in human cells following stabilization of topoisomerase-DNA cleavable complexes.
Kaufmann WK; Boyer JC; Estabrooks LL; Wilson SJ
Mol Cell Biol; 1991 Jul; 11(7):3711-8. PubMed ID: 1646393
[TBL] [Abstract][Full Text] [Related]
17. Phosphorylation of histone H2AX and activation of Mre11, Rad50, and Nbs1 in response to replication-dependent DNA double-strand breaks induced by mammalian DNA topoisomerase I cleavage complexes.
Furuta T; Takemura H; Liao ZY; Aune GJ; Redon C; Sedelnikova OA; Pilch DR; Rogakou EP; Celeste A; Chen HT; Nussenzweig A; Aladjem MI; Bonner WM; Pommier Y
J Biol Chem; 2003 May; 278(22):20303-12. PubMed ID: 12660252
[TBL] [Abstract][Full Text] [Related]
18. The benzylisoquinoline alkaloids, berberine and coptisine, act against camptothecin-resistant topoisomerase I mutants.
Inoue N; Terabayashi T; Takiguchi-Kawashima Y; Fujinami D; Matsuoka S; Kawano M; Tanaka K; Tsumura H; Ishizaki T; Narahara H; Kohda D; Nishida Y; Hanada K
Sci Rep; 2021 Apr; 11(1):7718. PubMed ID: 33833336
[TBL] [Abstract][Full Text] [Related]
19. Molecular and cytotoxic effects of camptothecin, a topoisomerase I inhibitor, on trypanosomes and Leishmania.
Bodley AL; Shapiro TA
Proc Natl Acad Sci U S A; 1995 Apr; 92(9):3726-30. PubMed ID: 7731973
[TBL] [Abstract][Full Text] [Related]
20. Interaction between replication forks and topoisomerase I-DNA cleavable complexes: studies in a cell-free SV40 DNA replication system.
Tsao YP; Russo A; Nyamuswa G; Silber R; Liu LF
Cancer Res; 1993 Dec; 53(24):5908-14. PubMed ID: 8261402
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
